Exploring the Future of Biosimilars: Market Growth, Trends, and COVID-19 Impact from 2023 to 2031

𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧
The biosimilar market is experiencing rapid growth as healthcare systems worldwide recognize the cost-saving potential and therapeutic efficacy of these drugs. Biosimilars are biologic medical products that are almost identical to original branded drugs but are typically more affordable. This blog post provides an in-depth analysis of the global biosimilar market size, share, and the impact of COVID-19. We will also explore market segmentation by resin type, application, technology, end-use industry, and regional forecasts from 2023 to 2031.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐚𝐧𝐝 𝐒𝐡𝐚𝐫𝐞
In 2023, the global biosimilar market was valued at approximately $X billion and is expected to grow at a CAGR of Y% during the forecast period. The increasing demand for cost-effective biologics, coupled with the expiration of patents for blockbuster biologics, drives the market growth. Key players include Sandoz, Teva Pharmaceuticals, and Pfizer, who lead with extensive portfolios and robust R&D investments.

𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐔𝐧𝐢𝐪𝐮𝐞 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.accuteresearch.com/request-for-free-sample/8194

𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬
The COVID-19 pandemic had a profound impact on the biosimilar market. Initially, the market faced challenges such as supply chain disruptions and delayed clinical trials. However, the pandemic also accelerated the adoption of biosimilars due to the urgent need to reduce healthcare costs and ensure the availability of essential treatments. Post-pandemic, the market is witnessing a surge in biosimilar approvals and launches, signaling strong growth prospects.

𝐁𝐲 𝐑𝐞𝐬𝐢𝐧 𝐓𝐲𝐩𝐞
Protein-based Biosimilars: These dominate the market due to their extensive use in treating chronic diseases like cancer and autoimmune disorders.
Non-protein Biosimilars: Emerging segment with potential applications in new therapeutic areas.

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
Oncology: The largest application segment, driven by the high prevalence of cancer and the need for affordable biologic therapies.
Autoimmune Diseases: Significant growth due to the rising incidence of diseases like rheumatoid arthritis and psoriasis.
Chronic Diseases: Increasing demand for biosimilars to treat conditions such as diabetes and growth hormone deficiencies.

𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲
Recombinant DNA Technology: The predominant technology used in the production of biosimilars, ensuring high efficacy and safety.
Monoclonal Antibody Technology: A growing segment due to its specificity and effectiveness in targeting disease pathways.

𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲
Hospitals: Major end-users, as hospitals are the primary centers for biologic treatments.
Specialty Clinics: Increasingly important due to the rise in outpatient treatments and specialized care.
Pharmacies: Growing segment as biosimilars become more accessible to patients through retail and online pharmacies.

𝐅𝐫𝐞𝐞 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.accuteresearch.com/request-for-customization/8194

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚
Market Leader: Dominates the market due to advanced healthcare infrastructure, high R&D investment, and favorable regulatory frameworks.
Growth Drivers: Increased adoption of biosimilars, patent expirations, and supportive government policies.
𝐄𝐮𝐫𝐨𝐩𝐞
Key Markets: Germany, France, and the UK lead in market size and growth.
Trends: Strong biosimilar uptake due to cost-containment measures and robust regulatory support from agencies like the EMA.
𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜
Emerging Market: Rapid growth attributed to increasing healthcare access, rising chronic disease burden, and supportive regulatory policies.
Challenges: Regulatory complexities and need for greater healthcare investment.
𝐋𝐚𝐭𝐢𝐧 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐚𝐧𝐝 𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 & 𝐀𝐟𝐫𝐢𝐜𝐚
Growth Potential: Moderate growth expected due to improving healthcare infrastructure and increasing awareness of biosimilars.
Challenges: Economic constraints and limited access to advanced biologic therapies.

𝐀𝐬𝐤 𝐚𝐛𝐨𝐮𝐭 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭- https://www.accuteresearch.com/buying-inquiry/8194

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

S NO 35/2, Bandhutva, Shiv Colony, Near Bus Stop, Pune-411043

info@accuteresearch.com

+91 92092 37178

𝐀𝐛𝐨𝐮𝐭 𝐀𝐜𝐜𝐮𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Accute Market Research is a prominent provider of market research and consulting services across diverse industries. The company offers extensive customized services for businesses and investors of all sizes worldwide.

Accute Market Research focuses on combining specialized market knowledge and research insights to consistently deliver exceptional results for our clients.

We specialize in technology, healthcare, aerospace & defence, automotive, agriculture, energy & power, and chemicals & materials industry verticals. The company provides market research, competitive intelligence, sentiment analysis, voice of customer, and strategic consulting services to companies worldwide.

This release was published on openPR.